Stay updated on Expanded Access Risdiplam in SMA Clinical Trial
Sign up to get notified when there's something new on the Expanded Access Risdiplam in SMA Clinical Trial page.

Latest updates to the Expanded Access Risdiplam in SMA Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedCore content updated with a government funding notice and a new Genetic and Rare Diseases Information Center resource; version updated from v3.1.0 to v3.2.0.SummaryDifference5%

- Check16 days agoChange DetectedVersion bump: from v3.0.2 to v3.1.0. No other content changes are specified.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check31 days agoChange DetectedPage updated to Revision: v3.0.2 from v3.0.1; 'Back to Top' removed.SummaryDifference0.3%

- Check38 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.3%

- Check45 days agoChange DetectedThe web page has updated its facility name and location details, specifically highlighting St. Louis, Missouri, while removing several previous location descriptors and medical resources.SummaryDifference4%

- Check59 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%

Stay in the know with updates to Expanded Access Risdiplam in SMA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Expanded Access Risdiplam in SMA Clinical Trial page.